Telephone: +61 3 9320 9555|info@mda.org.au

DMD

/Tag:DMD

Looking Back and Moving Forward

By | June 28th, 2017|disorders, information, news, research, trials|

Launch of National Duchenne Muscular Dystrophy Register On Monday November 15th 2010, the Director General of Health launched the Duchenne Muscular Dystrophy (DMD) [...]

DMD – A Guide for Parents

By | September 30th, 2016|

DMD - A Guide for Parents Introduction Most people reading this booklet for the first time will have just been told that their [...]

Respiratory & Ventilation

By | August 19th, 2016|

Respiratory considerations in neuromuscular disorders particularly Duchenne MD and SMA form a significant part of caring for and providing the best possible outcome [...]

Duchenne Muscular Dystrophy

By | July 23rd, 2016|

There are many types of muscular dystrophy (MD); all are caused by errors in genes (the units of inheritance that parents pass on [...]

Glossopharyngeal Breathing (GPB)

By | July 23rd, 2016|

Air Stacking or "Frog Breathing" Both inspiratory and, indirectly, expiratory muscle function can be assisted by "air stacking", technically known as "glossopharyngeal breathing" [...]

Ventilation Factsheet

By | July 23rd, 2016|

There are many different neuromuscular conditions in which weakness of the breathing muscles requires monitoring and treatment and may eventually need some form [...]

Duchenne MD research news update 2015

By | July 23rd, 2016|

There have been several developments in the past month with regard to the development of treatments for Duchenne MD. This includes two “firsts” [...]

Disappointing Research…

By | July 23rd, 2016|

exon skipping trial results released In a press release GlaxoSmithKline and Prosensa have said that the results of the phase 3 exon skipping [...]

Clinical trial DMD

By | July 23rd, 2016|

Duchenne muscular dystrophy Summit, a UK drug company, announced on the 9th December 2013 that a boy with Duchenne muscular dystrophy (DMD) had [...]

Clinical trial of new steroid for DMD

By | July 23rd, 2016|

ReveraGen BioPharma has announced the start of a Phase 1 clinical trial of a new steroidal drug, VBP15, for Duchenne muscular dystrophy (DMD). [...]